These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5361014)

  • 1. Effects of ethyl-alpha-p-chlorophenoxybutyrate (CPIB) on total cholesterol concentrations of rat aorta.
    Tolman EL; Tepperman J; Tepperman HM
    Proc Soc Exp Biol Med; 1969 Dec; 132(3):936-9. PubMed ID: 5361014
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of ethyl p-chlorophenoxyisobutyrate (CPIB) upon establishment and progression of experimental atherosclerosis in rabbits.
    Kritchevsky D; Sallata P; Tepper SA
    J Atheroscler Res; 1968; 8(5):755-61. PubMed ID: 5688373
    [No Abstract]   [Full Text] [Related]  

  • 3. CPIB and cholesterol esters.
    Robinson RW; Hagopian M
    J Atheroscler Res; 1968; 8(5):867. PubMed ID: 5688387
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of the ethyl ester and sodium salt of alpha-p-chlorophenoxyisobutyric acid on cholesterol oxidation by rat liver mitochondria.
    Kritchevsky D; Tepper SA; Sallata P; Kabakjian JR; Cristofalo VJ
    Proc Soc Exp Biol Med; 1969 Oct; 132(1):79-82. PubMed ID: 5344871
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of ethyl alpha-p. chlorophenoxyisobutyrate on ethanol-induced hepatic steatosis in the rat.
    Brown DF
    Metabolism; 1966 Oct; 15(10):868-73. PubMed ID: 5923523
    [No Abstract]   [Full Text] [Related]  

  • 6. [Derivatives of para-chlorphenoxyisobutyric acid as hypocholesteremic agents].
    Klebanov BM
    Farmakol Toksikol; 1970; 33(3):324-7. PubMed ID: 5453029
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of chlorophenoxyisobutyrate (CPIB) on thyroid parameters.
    Hansen JM
    Acta Endocrinol (Copenh); 1969 Feb; 60(2):294-302. PubMed ID: 4979609
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum lipid responses to ethyl-p-chlorophenoxyisobutyrate with different dietary fats.
    Kokatnur MG; Malcom GT; Martinez RD
    Metabolism; 1969 Jan; 18(1):73-80. PubMed ID: 5764810
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of hypocholesterolemic drugs on adrenal corticosteroid secretion.
    Huffman DH; Azarnoff DL
    Steroids; 1967 Jan; 9(1):41-51. PubMed ID: 6030919
    [No Abstract]   [Full Text] [Related]  

  • 10. Increase of hepatic mitochondria on administration of ethyl alpha-p-chlorophenoxyisobutyrate to the rat.
    Kurup CK; Aithal HN; Ramasarma T
    Biochem J; 1970 Mar; 116(5):773-9. PubMed ID: 5441366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol esters and hypocholesterolaemic drugs.
    Bowyer DE; Patelski J; Howard AN; Gresham GA
    J Atheroscler Res; 1968; 8(5):864-5. PubMed ID: 5688385
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of chlorophenoxyisobutyric acid (CPIB) on adrenaline-induced lipolysis in vitro.
    Blackard WG; Kokatnur MG
    J Atheroscler Res; 1968; 8(1):189-91. PubMed ID: 5642102
    [No Abstract]   [Full Text] [Related]  

  • 13. Biosynthesis of cholesterol by the bovine aorta and the mechanism of action of alpha-para-chlorophenoxyisobutyric acid.
    Walsh MR; Teal SW; Gamble W
    Arch Biochem Biophys; 1969 Mar; 130(1):7-18. PubMed ID: 5778686
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of CPIB ester on plasma free fatty acid levels in man.
    Rifkind BM
    Metabolism; 1966 Aug; 15(8):673-5. PubMed ID: 5341113
    [No Abstract]   [Full Text] [Related]  

  • 15. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent.
    Timms AR; Kelly LA; Ho RS; Trapold JH
    Biochem Pharmacol; 1969 Aug; 18(8):1861-71. PubMed ID: 5811622
    [No Abstract]   [Full Text] [Related]  

  • 16. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat.
    Hess R; Stäubli W; Riess W
    Nature; 1965 Nov; 208(5013):856-8. PubMed ID: 5870099
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of ethyl chlorophenoxyisobutyrate (CPIB) on the uptake of triglyceride fatty acids, activity of lipoprotein lipase and lipogenesis from glucose in fat tissue of rats.
    Nestel PJ; Austin W
    J Atheroscler Res; 1968; 8(5):827-33. PubMed ID: 5688379
    [No Abstract]   [Full Text] [Related]  

  • 18. REDUCTION OF SERUM TRIGLYCERIDES AND CHOLESTEROL BY ETHYL P-CHLOROPHENOXY-ISOBUTYRATE (CPIB).
    BEST MM; DUNCAN CH
    Am J Cardiol; 1965 Feb; 15():230-3. PubMed ID: 14254816
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of clofibrate on fibrinolysis, platelet stickiness, plasma-fibrinogen, and serum-cholesterol.
    Chakrabarti R; Fearnley GR; Evans JF
    Lancet; 1968 Nov; 2(7576):1007-9. PubMed ID: 4176340
    [No Abstract]   [Full Text] [Related]  

  • 20. HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.
    BEST MM; DUNCAN CH
    J Lab Clin Med; 1964 Oct; 64():634-42. PubMed ID: 14233152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.